Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease
Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: Long-term results
Ursolic acid causes DNA-damage, P53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo
Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway
Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through AMPK alpha-mediated reduction of DNA methyltransferase 1
Ursolic acid induces cell cycle arrest and apoptosis of gallbladder carcinoma cells
Ursodeoxycholic acid in cystic fibrosis-associated liver disease
Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins
Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells
Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells
Ursolic Acid and Oleanolic Acid Suppress Preneoplastic Lesions Induced by 1,2-Dimethylhydrazine in Rat Colon
Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet
Ursolic acid directly promotes protein accretion in myotubes but does not affect myoblast proliferation
Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of ROR lambda t Protein
Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis
Ursolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth
Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis
Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells
Ursolic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis
Ursodeoxycholic acid, an inhibitor of hepatocyte nuclear factor 1 alpha, does not increase the systemic exposure of pitavastatin
Ursolic acid is a PPAR-alpha agonist that regulates hepatic lipid metabolism
Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease
Ursolic Acid, a Pentacyclic Triterpene from Sambucus australis, Prevents Abdominal Adiposity in Mice Fed a High-Fat Diet
Ursolic acid and it is emerging anti-neoplastic effects in systemic malignancies
Ursodeoxycholic Acid Amides As Novel Glucocorticoid Receptor Modulators
Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling
Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro
Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis